Pills masthead

Kristin Arnold

Kristin Arnold

Vice President of Research and Development

Kristin Arnold joined Lannett Company as vice president of research and development in 2017. In this role, she leads the R&D effort for new internally developed products focusing on generic and specialty finished products, and provides scientific input for third party projects. Kristin came to the company with strong technical expertise in pharmaceutical development and regulatory knowledge spanning 20 years of generic and specialty pharmaceutical product development and launch experience with companies such as Alvogen, URL/Mutual, and Alpharma (now Teva).

“Growth can present challenges, as we move from acquiring companies to becoming a multi-site entity with aligned objectives and common goals. Working through significant change throughout the organization, we are building the infrastructure to integrate people, systems, and technology for continued future expansion.”

An accomplished scientist, Kristin is a member of the American Chemical Society (ACS) and the American Association of Pharmaceutical Scientists, with 21 scientific publications and 8 US patents. Kristin holds a PhD in physical organic chemistry from the University of Miami.